scholarly journals Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults11The names and affiliations of the Task Force members are listed on page v of this supplement and at http://www.thecommunityguide.org22Some of this material was published previously in: Shefer A, Briss P, Rodewald L, et al. Improving immunization coverage rates: an evidence-based review of the literature. Epidemiol Rev 1999;20:96–142.

2000 ◽  
Vol 18 (1) ◽  
pp. 97-140 ◽  
Author(s):  
Peter A. Briss ◽  
Lance E. Rodewald ◽  
Alan R. Hinman ◽  
Abigail M. Shefer ◽  
Raymond A. Strikas ◽  
...  
1999 ◽  
Vol 21 (1) ◽  
pp. 96-142 ◽  
Author(s):  
A. Shefer ◽  
P. Briss ◽  
L. Rodewald ◽  
R. Bernier ◽  
R. Strikas ◽  
...  

1999 ◽  
Vol 5 (5) ◽  
pp. 933-940
Author(s):  
O. G. Al Sheikh ◽  
J. I. Al Samarrai ◽  
M. M. Al Sumaidaie ◽  
S. A. Mohammad ◽  
A. A. Al Dujaily

We assessed vaccination coverage rates among children born between 1989 and 1994 [0-2 years of age]and tried to find the underlying causes of incomplete immunization. Of 662 children surveyed, 326 were from Tikrit city [urban]and 336 were from three rural villages. The coverage rates for BCG, DPT-OPV [first dose], DPT-OPV [second dose], DPT-OPV [third dose], measles, MMR, and DPT-OPV [first booster]were 97%, 97%, 94%, 92%, 83%, 70% and 59% respectively in Tikrit city; in rural areas they were 92%, 65%, 57%, 41%, 42%, 32%, and 25% respectively. The most common causes of incomplete immunization were unawareness and ignorance for both urban and rural areas. The percentage of children completely immunized declined between 1989 and 1994, both in urban and rural areas


2019 ◽  
Vol 29 (Supplement_4) ◽  
Author(s):  
L Pastore Celentano

Abstract Background Vaccination coverage rates in the European Union (EU) vary considerably across countries and there has been a decline for some diseases in some countries in recent years. Methods The ECDC supports member states in their vaccination programmes through a range of activities, including identification of threats, surveillance, international collaboration, scientific working groups, assessments of national vaccination programmes, and communication activities. Results For the first dose of the vaccine against measles, coverage ranges from 85% in Italy to 99% in Luxembourg and Hungary, with the average for the EU (93.6%) falling below what is required to ensure herd immunity. Uptake of the second dose against measles reached the target of 95% in only four countries in 2017, compared to 14 in 2007. Conclusions Despite the fact that there are safe and efficient vaccines, there seems to be a crisis of confidence in them. Each EU citizen should receive correct evidence-based information on vaccines and have the same immunisation opportunities.


Sign in / Sign up

Export Citation Format

Share Document